Email address
[email protected]Contact number
+43 1 534 80About
Provided by BINDER GRÖSSWANG Rechtsanwälte GmbH
Intensive competition, a large und constant capacity for innovation, and at the same time a high degree of regulation: this is the challenging context confronting the life sciences and healthcare sector. Binder Grösswang’s expertise in dealing with the complex legal issues that can arise in this sector has been accrued over many years.
Particularly when operating in such a complex environment, excellent legal advice is essential in order to successfully meet the challenges of the market and take the best possible advantage of the opportunities that emerge. Therefore, Binder Grösswang’s multidisciplinary life sciences team is composed of experts from the entire spectrum of practice areas: from M&A through regulatory, finance, tax and competition law to intellectual property law. This enables us to address the needs of our clients through comprehensive, interdisciplinary counsel.
We support companies and their investors from the entire sector, including the fields of pharmaceuticals, medical technology, biotechnology, diagnostics and healthcare. We advise numerous clients – from start-ups to multinational groups – on a wide range of complex issues, focussing on legally sound, economically resilient solutions.
Members
Provided by BINDER GRÖSSWANG Rechtsanwälte GmbH
Andreas Hable
Christian Zwick
Johannes Barbist
Regina Kröll
Clients
Provided by BINDER GRÖSSWANG Rechtsanwälte GmbH
Agfa HealthCare
Alexion Pharmaceutical Inc
Asahi Kasei
Corza Health
Jazz Pharmaceuticals
Johnson & Johnson
Medicus AI
Novartis Sandoz
Portola Pharmaceuticals Inc.
SeneCura
Thermo Fisher Scientific
UNIQA
Vertellus
Industries
Provided by BINDER GRÖSSWANG Rechtsanwälte GmbH
Food sector
Insurance companies
Pharmaceuticals
Start-ups